openPR Logo
Press release

20 OF THE WORLD’S LEADING FERTILITY EXPERTS COME TOGETHER FOR FREE VIRTUAL CONFERENCE AND FUNDRAISER - MAY 12-13, 2018

05-11-2018 10:36 AM CET | Health & Medicine

Press release from: teaandcopper

20 OF THE WORLD’S LEADING FERTILITY EXPERTS COME TOGETHER

Speakers focused on fertility, pre-natal, and post-partum health for women with PCOS

[Worldwide, May 12-13, 2018] This Mothers’ Day weekend, over 20 of the world’s leading fertility experts are coming together to share their knowledge in a free virtual conference for women with poly-cystic ovarian syndrome (PCOS) as a fundraiser for the PCOS Awareness Association (PCOSAA.)

This not-for-profit online event includes speakers such as Fairhaven Health’s Dr. Chris Meletis and Suzanne Munson, acupuncturist Josie Bouchier, Clinical Social Worker Amira Posner, Registered Dietician Nutritionist Crystal Karges, personal trainer Deanna Schober, therapist and coach Maria Rothenburger, author Amy Riley, and more!

Covering topics ranging from nutritional timing for optimal fertility, through safe supplementation, weight loss, mindset, masculine and feminine energy, certainty, supporting your relationship through a fertility journey, and more, these experts are sharing everything they know in a series of 30 minute interviews. The interviews will be released one-by-one over May 12-13, and will remain available for free streaming all week long.

Free registration is open at www.nourishsummit.com until May 13, 2018.

The Nourish Fertility Summit is a no-cost, not-for-profit digital conference for women with PCOS to discover new ideas and learn from the world’s leading experts on fertility, pre-natal, and post-partum health. Founded and sponsored by a PCOS-focused nutritionist, registrants will gain access to a wide array of ideas that can support their overall health, fertility, and journey into parenthood. Registration is free at www.nourishsummit.com

If you would like more information about the Nourish Fertility Summit, please contact Cheryl Woodhouse, Organizer, at cheryl@teaandcopper.com or 604-316-3138.

PO BOX 3113, Cultus Lake Stn Main
Cultus Lake, BC Canada
V2R 5X2

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 20 OF THE WORLD’S LEADING FERTILITY EXPERTS COME TOGETHER FOR FREE VIRTUAL CONFERENCE AND FUNDRAISER - MAY 12-13, 2018 here

News-ID: 1046464 • Views:

More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms